XORTX Therapeutics Inc (XRTX) — Capital Reinvestment Ratio
Latest as of December 2020:
0.00x
XORTX Therapeutics Inc (XRTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (CA$1.57 Million) in capital expenditures (CA$2.84K). See free cash flow generation of XORTX Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
CA$1.57 Million
CAD
Capital Expenditures
CA$2.84K
CAD
Data as of
Dec 2020
Most recent filing
XORTX Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks XORTX Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for XORTX Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for XORTX Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see market value of XORTX Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.01x | CA$91.17K | CA$1.17K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow